Concert Pharmaceuticals, Inc. (CNCE) Earnings
|
Expand Research on CNCE
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -12.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/4/23 | Q123 | N/A | -$0.81 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/6/23 | Q422 | N/A | -$0.64 | N/A | N/A | $113.33K | N/A | N/A | N/A | ||
| 3/2/23 | Q422 | N/A | -$0.64 | N/A | N/A | $113.33K | N/A | N/A | N/A | ||
| 11/7/22 | Q322 | -$0.78 | -$0.59 | -$0.19 | $543K | $165K | N/A |  | | Details | |
| 8/4/22 | Q222 | -$0.59 | -$0.89 | +$0.30 | N/A | N/A | N/A | | | Details | |
| 5/5/22 |  |
Q122 | -$1.03 | -$0.91 | -$0.12 | N/A | $80K | N/A | | | Details |
| 3/3/22 | |
Q421 | -$1.01 | -$0.73 | -$0.28 | $13K | $20K | N/A | | | Details |
| 11/9/21 | |
Q321 | -$0.78 | -$0.81 | +$0.03 | $543K | $50K | N/A | | | Details |
